Daclatasvir Dihydrochloride and NovoLog PenFill
Determining the interaction of Daclatasvir Dihydrochloride and NovoLog PenFill and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: daclatasvir
Brand name: Daklinza
Synonyms: Daclatasvir
Generic Name: insulin aspart
Brand name: Fiasp, NovoLog, NovoLog FlexPen, NovoLog PenFill, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Daclatasvir Dihydrochloride-Novoseven
- Daclatasvir Dihydrochloride-NovoSeven RT
- Daclatasvir Dihydrochloride-NovoSeven RT with MixPro injection
- Daclatasvir Dihydrochloride-Novothyrox
- Daclatasvir Dihydrochloride-Noxafil
- Daclatasvir Dihydrochloride-Noxafil (Posaconazole Delayed-Release Tablets)
- NovoLog PenFill-Daclizumab
- NovoLog PenFill-Daclizumab Subcutaneous
- NovoLog PenFill-Dacogen
- NovoLog PenFill-Dacomitinib
- NovoLog PenFill-Dactinomycin
- NovoLog PenFill-Dactinomycin Injection